EDITHAL Trademark

Trademark Overview

On Thursday, April 7, 2022, a trademark application was filed for EDITHAL with the United States Patent and Trademark Office. The USPTO has given the EDITHAL trademark a serial number of 97352213. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, August 8, 2024. This trademark is owned by Editas Medicine, Inc.. The EDITHAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials for others; pharmaceutical research and development services; medical research; scientific research; providing medical and scientific research information in the field of pharmaceuticals for the treatment of Beta Thalassemia
edithal

General Information

Serial Number97352213
Word MarkEDITHAL
Filing DateThursday, April 7, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, August 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements

Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others; pharmaceutical research and development services; medical research; scientific research; providing medical and scientific research information in the field of pharmaceuticals for the treatment of Beta Thalassemia

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 12, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEditas Medicine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameEditas Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Trademark Events

Event DateEvent Description
Monday, April 11, 2022NEW APPLICATION ENTERED
Tuesday, April 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 20, 2022ASSIGNED TO EXAMINER
Monday, July 25, 2022NON-FINAL ACTION WRITTEN
Monday, July 25, 2022NON-FINAL ACTION E-MAILED
Monday, July 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 14, 2023SOU EXTENSION 1 FILED
Friday, July 14, 2023SOU EXTENSION 1 GRANTED
Tuesday, July 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2024SOU EXTENSION 2 FILED
Thursday, August 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 8, 2024SOU EXTENSION 3 GRANTED
Thursday, August 8, 2024SOU EXTENSION 3 FILED
Saturday, January 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 25, 2024SOU EXTENSION 2 GRANTED

Related Keywords

edithal research medical scientific field information pharmaceuticals beta thalassemia providing treatment